ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,665Medicare Part D Prescriptions Filled, Including Refills

Rank: 56 out of 223

$497K Total Retail Price of All Prescriptions

Rank: 66 out of 223

370 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 370 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 370 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

4% of this provider’s 7,368 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
LEVOTHYROXINE SODIUM 366 307 1 2
SIMVASTATIN 331 307 2 1
HYDROCODONE-ACETAMINOPHEN 323 220 S3 3 5
LISINOPRIL 279 252 4 4
ZOLPIDEM TARTRATE 216 140 5 8
OMEPRAZOLE 213 186 6 3
METFORMIN HCL ER 199 189 7 41
AMLODIPINE BESYLATE 197 176 8 6
GLIMEPIRIDE 186 180 9 30
FUROSEMIDE 146 140 10 9
CITALOPRAM HBR 138 115 11 16
METFORMIN HCL 134 134 12 7
GABAPENTIN 133 106 13 10
PRAVASTATIN SODIUM 117 112 14 15
TRAZODONE HCL 111 93 15 22
WARFARIN SODIUM 110 102 16 11
LOSARTAN POTASSIUM 110 88 16 14
LOSARTAN-HYDROCHLOROTHIAZIDE 105 97 18 31
TAMSULOSIN HCL 100 92 19 26
MELOXICAM 100 100 19 33
BENAZEPRIL HCL 98 95 21 57
SERTRALINE HCL 96 78 22 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 92 79 23 29
POTASSIUM CHLORIDE 91 71 24 12
METOPROLOL SUCCINATE 90 76 25 20
NAMENDA 88 88 26 48
TRAMADOL HCL 87 59 27 18
HYDROCHLOROTHIAZIDE 82 75 28 13
ALENDRONATE SODIUM 81 79 29 19
DONEPEZIL HCL 76 69 30 36
ATORVASTATIN CALCIUM 75 73 31 17
IBUPROFEN 75 70 31 46
CYMBALTA 70 28 33 40
FENOFIBRATE 68 68 34 38
CARVEDILOL 67 62 35 23
CARBIDOPA-LEVODOPA 66 56 36 101
GLIPIZIDE ER 61 61 37 98
PREMARIN 61 60 R 37 115
PAROXETINE HCL 60 60 39 52
LOVASTATIN 58 58 40 51
TRIAMTERENE-HCTZ 58 54 40 39
DICLOFENAC SODIUM 56 42 42 76
ORPHENADRINE CITRATE 55 37 R 43 240
JANUVIA 55 55 43 66
CYCLOBENZAPRINE HCL 55 31 R 43 79
ALLOPURINOL 53 49 46 28
EVISTA 52 40 47 92
FLUTICASONE PROPIONATE 50 41 48 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.